医疗严重程度-诊断相关分组分类是否应用于报销?Elixhauser合并症与医疗费用分析
该单中心回顾性研究分析了2013至2017年1243例全膝关节置换术和897例全髋关节置换术患者,发现仅39例(1.8%)被归为MS-DRG 469;凝血障碍、电解质紊乱、神经退行性疾病和精神障碍与MS-DRG 469分类及费用增加相关,但另有13种合并症仅与费用增加相关而未纳入MS-DRG分类;作者认为CMS现行风险调整系统与最昂贵诊断相关性低,需扩展。
要点
- 仅39例(1.8%)关节置换患者被归为MS-DRG 469。
- 凝血障碍、电解质紊乱、神经退行性疾病和精神障碍与MS-DRG 469分类及费用增加相关。
- 另有13种合并症仅与费用增加相关,未纳入MS-DRG分类。
核心结论
- 本研究表明CMS现行MS-DRG 469风险调整系统与最昂贵诊断相关性低,作者认为亟需扩展CMS对全髋和全膝关节置换术的风险调整系统。
研究设计与样本
- 单中心回顾性研究,纳入2013至2017年1243例全膝关节置换术和897例全髋关节置换术患者,分析Elixhauser合并症与MS-DRG 469分类及医疗费用的关系。
主要发现
- 39例患者(1.8%)被归为MS-DRG 469。
- 单因素和多因素logistic分析显示,凝血障碍、电解质紊乱、神经退行性疾病和精神障碍与复杂性分类增加显著相关。
- 上述4种合并症也与医疗费用增加相关;另有13种合并症可预测费用增加但与MS-DRG分类无关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The Center for Medicare and Medicaid Services (CMS) classifies reimbursement for total hip arthroplasty (THA) and total knee arthroplasty (TKA) based on Medical Severity-Diagnosis Related Groups (MS-DRGs) 469 (with major complication/comorbidity) and 470 (without major complication/comorbidity). The validated Elixhauser comorbidity index includes 31 variables that may be associated with MS-DRG 469. However, we hypothesized that these comorbidities may not be the most predictive of increased cost of care. METHODS: Elixhauser comorbidities were retrospectively examined for 1243 TKAs and 897 THAs from 2013 to 2017 at a single center. Comorbidities were investigated in univariable analysis and significant variables associated with MS-DRG 469, and cost of care was further investigated in a multivariable regression to determine which were most predictive of the increased complexity classification assigned by CMS vs true increased cost of care. RESULTS: Thirty-nine patients (1.8%) were classified as MS-DRG 469. Univariable and multivariable logistic analysis revealed that coagulopathy, electrolyte disorders, neurodegenerative disorders, and psychosis were significantly associated with an increased complexity classification. These 4 comorbidities were also associated with increased cost of care; however, 13 additional comorbidities were also predictive of increased cost but not MS-DRG classification. CONCLUSIONS: Patient comorbidities have been shown to increase complications and cost of care for arthroplasty patients. To date, however, the only risk adjustment provided has been the 469 DRG code. This study demonstrates little correlation to the current system with the most expensive diagnoses. Consequently, an expansion of the current risk adjustment system for THA and TKA provided by CMS appears greatly needed.
引用
- Ryan SP, Plate JF, Goltz DE, et al. Should Medical Severity-Diagnosis Related Group Classification Be Utilized for Reimbursement? An Analysis of Elixhauser Comorbidities and Cost of Care. J Arthroplasty. 2019. PMID: 30904362. doi:10.1016/j.arth.2019.02.045
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。